The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
A network view of disease and compound screening
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Chang, H., Anway, M. D., Rekow, S. S., & Skinner, M. K. (2006) · Endocrinology · doi:10.1210/en.2006-0987 · Cited by 161
Retracted(1988) · Cited by 16,582
Gene expression profiling predicts clinical outcome of breast cancer
van 't Veer, L. J., Dai, H., van de Vijver, M. J., He, Y. D., Hart, A. A. M., Mao, M., Peterse, H. L., van der Kooy, K., Marton, M. J., Witteveen, A. T., et al. (2002) · Nature · doi:10.1038/415530a · Cited by 9,536
Self-citationGenome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls
The Wellcome Trust Case Control Consortium, Management Committee, Burton, P. R., Clayton, D. G., Cardon, L. R., Craddock, N., Deloukas, P., Duncanson, A., Kwiatkowski, D. P., McCarthy, M. I., et al. (2007) · Nature · doi:10.1038/nature05911 · Cited by 9,442
Network biology: understanding the cell's functional organization
Barabási, A.-L., & Oltvai, Z. N. (2004) · Nature Reviews Genetics · doi:10.1038/nrg1272 · Cited by 7,903
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
The Cancer Genome Atlas Research Network (2008) · Nature · doi:10.1038/nature07385 · Cited by 7,735
A Gene-Expression Signature as a Predictor of Survival in Breast Cancer
van de Vijver, M. J., He, Y. D., van 't Veer, L. J., Dai, H., Hart, A. A. M., Voskuil, D. W., Schreiber, G. J., Peterse, J. L., Roberts, C., Marton, M. J., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021967 · Cited by 6,488
Self-citationAn Integrated Genomic Analysis of Human Glioblastoma Multiforme
Parsons, D. W., Jones, S., Zhang, X., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Siu, I.-M., Gallia, G. L., et al. (2008) · Science · doi:10.1126/science.1164382 · Cited by 5,857
Lamb, J., Crawford, E. D., Peck, D., Modell, J. W., Blat, I. C., Wrobel, M. J., Lerner, J., Brunet, J.-P., Subramanian, A., Ross, K. N., et al. (2006) · Science · doi:10.1126/science.1132939 · Cited by 5,257
Network pharmacology: the next paradigm in drug discovery
Hopkins, A. L. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.118 · Cited by 4,622
Cited by
Network medicine: a network-based approach to human disease
Barabási, A.-L., Gulbahce, N., & Loscalzo, J. (2011) · Nature Reviews Genetics · doi:10.1038/nrg2918 · Cited by 5,034
Integrated Systems Approach Identifies Genetic Nodes and Networks in Late-Onset Alzheimer’s Disease
Zhang, B., Gaiteri, C., Bodea, L.-G., Wang, Z., McElwee, J., Podtelezhnikov, A. A., Zhang, C., Xie, T., Tran, L., Dobrin, R., et al. (2013) · Cell · doi:10.1016/j.cell.2013.03.030 · Cited by 1,657
“Targeting such causal networks in ways that restore them to a normal state has been proposed as a path to treat disease (Schadt et al., 2009), but this potential has never been realized for LOAD.”
BackgroundSelf-citationTraditional Chinese medicine network pharmacology: theory, methodology and application
LI, S., & ZHANG, B. (2013) · Chinese Journal of Natural Medicines · doi:10.1016/s1875-5364(13)60037-0 · Cited by 1,329
Structure and dynamics of molecular networks: A novel paradigm of drug discovery
Csermely, P., Korcsmáros, T., Kiss, H. J. M., London, G., & Nussinov, R. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.01.016 · Cited by 892
Molecular networks as sensors and drivers of common human diseases
Schadt, E. E. (2009) · Nature · doi:10.1038/nature08454 · Cited by 806
Self-citationSirota, M., Dudley, J. T., Kim, J., Chiang, A. P., Morgan, A. A., Sweet-Cordero, A., Sage, J., & Butte, A. J. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3001318 · Cited by 799
Validating therapeutic targets through human genetics
Plenge, R. M., Scolnick, E. M., & Altshuler, D. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4051 · Cited by 712
Computational solutions to large‐scale data management and analysis
Schadt, E. E., Linderman, M. D., Sorenson, J., Lee, L., & Nolan, G. P. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2857 · Cited by 631
Self-citationSystems genetics approaches to understand complex traits
Civelek, M., & Lusis, A. J. (2014) · Nature Reviews Genetics · doi:10.1038/nrg3575 · Cited by 621
Yu, W., Liu, T., Valdez, R., Gwinn, M., & Khoury, M. J. (2010) · BMC Medical Informatics and Decision Making · doi:10.1186/1472-6947-10-16 · Cited by 508
Data mining in clinical big data: the frequently used databases, steps, and methodological models
Wu, W.-T., Li, Y.-J., Feng, A.-Z., Li, L., Huang, T., Xu, A.-D., & Lyu, J. (2021) · Military Medical Research · doi:10.1186/s40779-021-00338-z · Cited by 505
In silico methods for drug repurposing and pharmacology
Hodos, R. A., Kidd, B. A., Shameer, K., Readhead, B. P., & Dudley, J. T. (2016) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1337 · Cited by 326
In silico repositioning of approved drugs for rare and neglected diseases
Ekins, S., Williams, A. J., Krasowski, M. D., & Freundlich, J. S. (2011) · Drug Discovery Today · doi:10.1016/j.drudis.2011.02.016 · Cited by 288
Systems biology and the future of medicine
Loscalzo, J., & Barabasi, A. (2011) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.144 · Cited by 287
The genetics of multiple sclerosis: an up‐to‐date review
Gourraud, P., Harbo, H. F., Hauser, S. L., & Baranzini, S. E. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01134.x · Cited by 282
Envisioning the future of early anticancer drug development
Yap, T. A., Sandhu, S. K., Workman, P., & de Bono, J. S. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2870 · Cited by 281
Methods for biological data integration: perspectives and challenges
Gligorijević, V., & Pržulj, N. (2015) · Journal of The Royal Society Interface · doi:10.1098/rsif.2015.0571 · Cited by 275
Software for systems biology: from tools to integrated platforms
Ghosh, S., Matsuoka, Y., Asai, Y., Hsin, K.-Y., & Kitano, H. (2011) · Nature Reviews Genetics · doi:10.1038/nrg3096 · Cited by 260
Zhu, J., Sova, P., Xu, Q., Dombek, K. M., Xu, E. Y., Vu, H., Tu, Z., Brem, R. B., Bumgarner, R. E., & Schadt, E. E. (2012) · PLoS Biology · doi:10.1371/journal.pbio.1001301 · Cited by 205
“Our results indicate that the incorporation of metabolite levels into the network reconstruction process significantly enhanced the utility of the network-based models [46,47].”
ResultAlbertini, C., Salerno, A., de Sena Murteira Pinheiro, P., & Bolognesi, M. L. (2021) · Medicinal Research Reviews · doi:10.1002/med.21699 · Cited by 179
Genome-environment interactions that modulate aging: powerful targets for drug discovery
de Magalhães, J. P., Wuttke, D., Wood, S. H., Plank, M., & Vora, C. (2012) · Pharmacological Reviews · doi:10.1124/pr.110.004499 · Cited by 136
Xiao, X., Moreno-Moral, A., Rotival, M., Bottolo, L., & Petretto, E. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004006 · Cited by 63
Miller, J. A., Menon, V., Goldy, J., Kaykas, A., Lee, C.-K., Smith, K. A., Shen, E. H., Phillips, J. W., Lein, E. S., & Hawrylycz, M. J. (2014) · BMC Genomics · doi:10.1186/1471-2164-15-154 · Cited by 48
Evolving toward a human-cell based and multiscale approach to drug discovery for CNS disorders
Schadt, E. E., Buchanan, S., Brennand, K. J., & Merchant, K. M. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00252 · Cited by 39
Self-citation
Metadata
- Authors
- Schadt, E. E., Friend, S. H., & Shaywitz, D. A.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2009-04
- Volume
- 8
- Issue
- 4
- Pages
- 286-295
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W1970263201
- Cited by
- 291
- References
- 58
- FWCI
- 1.62
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.